Morocco
10 stories from this country.
-
AMMPS recalls one batch of Pfizer’s Nivestim over cold-chain temperature recording incident
Morocco's medicines regulator has ordered an immediate halt to distribution and use of batch NG0631 of Nivestim 30 MU/0.5 ml after a cold-chain temperature recording system incident, with…
-
Morocco’s AMMPS moves cosmetic raw material import applications online
The Agence Marocaine du Médicament et des Produits de Santé has introduced an electronic-only submission process for import applications of raw materials used in local cosmetic and personal…
-
AMMPS recalls one batch of Vinrab rabies immunoglobulin over non-conformity
The Agence Marocaine du Médicament et des Produits de Santé has ordered a batch recall of Vinrab rabies immunoglobulin after detecting a non-conformity; the responsible company is MARBIO.
-
Morocco’s AMMPS signs partnership with standards institute IMANOR
The Agence Marocaine du Médicament et des Produits de Santé has signed a partnership agreement with the Institut Marocain de Normalisation to strengthen collaboration on standards, certification and…
-
Morocco’s AMMPS opens applications for clinical trial site accreditation
The Agence Marocaine du Médicament et des Produits de Santé has begun accepting accreditation applications for sites conducting clinical trials of experimental medicines and clinical investigations of medical…
-
Morocco’s AMMPS updates batch release checklist for vaccines and sera
The Agence Marocaine du Médicament et des Produits de Santé has updated the checklist for batch release applications for vaccines and sera, effective 22 September 2026, clarifying required…
-
Morocco’s AMMPS reminds industry of pre-clearance duty for drug advertising
The Agence Marocaine du Médicament et des Produits de Santé has reminded pharmaceutical manufacturers that all medicine advertising and promotional materials must be declared to the authority before…
-
Morocco’s AMMPS marks World Patient Safety Day with medication safety call
The Agence Marocaine du Médicament et des Produits de Santé has issued guidance for health professionals and patients on safe medication use in non-communicable diseases to mark World…
-
Morocco recalls two batches of Cardioaspirine 100 mg after temperature excursion
The Agence Marocaine du Médicament et des Produits de Santé has recalled two batches of Cardioaspirine 100 mg gastro-resistant tablets after a temperature deviation during transport.
-
Morocco tightens rules on medical samples carried by pharmaceutical representatives
The Agence Marocaine du Médicament et des Produits de Santé will require a signed commitment declaration from medical representatives, responsible pharmacists and agency heads when processing applications to…